Literature DB >> 11273888

Should we still use iron dextran in hemodialysis patients?

W H Hörl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11273888     DOI： 10.1016/s0272-6386(01)80137-2

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  3 in total

Review 1.  The role of iron supplementation during epoietin treatment for cancer-related anemia.

Authors:  M Hedenus; G Birgegård
Journal:  Med Oncol       Date:  2008-05-13       Impact factor: 3.064

2.  Overview of clinical trials in the treatment of iron deficiency with iron-acetyl-aspartylated casein.

Authors:  Flavio Lazzari; Maria Carrara
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

3.  Beneficial Effects of Oral Iron in Japanese Patients on Hemodialysis.

Authors:  Toru Sanai; Takashi Ono; Toma Fukumitsu
Journal:  Intern Med       Date:  2017-08-21       Impact factor: 1.271
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.